It does not receive public funding
Editor in chief:

Facebook Twitter Youtube Instagram LinkedIn

Labomar supplements land on the stock exchange

Debut in the Milan Aim segment on Monday 5 October

Labomar, a nutraceutical company based in the province of Treviso and active internationally, has received the admission of its ordinary shares to trading on the Aim Italia segment of the Stock Exchange. The start of trading is set for Monday 5 October. The placement price was set at € 6 per share, equal to a market capitalization of € 110.9 million.

“We are very proud of the outcome of the IPO process,” commented Walter Bertin, founder and CEO of Labomar. “Thanks to the success of the listing we will have the resources to carry out our projects. We intend to consolidate our position in the Italian market and continue our geographical expansion by also developing through external lines and, after the successful acquisition of ImportFab in Canada, evaluating possible new acquisitions in other countries ".

Founded by Walter Bertin in 1998, Labomar closed the first half of 2020 with revenues of 33 million euros. In 2019, turnover was 56.7 million, with a net profit of 5.7 million.

hef - 13811

EFA News - European Food Agency